Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;37(5):1049-1051.
doi: 10.1007/s00467-021-05359-3. Epub 2021 Dec 17.

Non-lupus full-house nephropathy-immune dysregulation as a rare cause of pediatric nephrotic syndrome: Questions

Affiliations

Non-lupus full-house nephropathy-immune dysregulation as a rare cause of pediatric nephrotic syndrome: Questions

Orsolya Horváth et al. Pediatr Nephrol. 2022 May.
No abstract available

Keywords: Autoimmunity; Lupus nephritis; Nephrotic syndrome (NS); Primary immunodeficiency (PID); “Full-house” nephropathy (FHN).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Patient flow chart. NS indicates nephrotic syndrome
Fig. 2
Fig. 2
Histopathologic findings in the non-lupus “full-house” nephropathy case. (1) “Full-house staining” by immunofluorescence: deposits are seen mainly along the glomerular basement membrane and scattered at mesangial sites. (2) Light microscopy showing diffuse mesangial matrix expansion in the glomeruli (arrows, middle, upper panel) and focal endocapillary/mesangial proliferation (asterisks); diffuse thickening of the glomerular basement membrane (arrow 1) with hyaline pseudothrombi (number sign, arrow 2, middle, lower panel). PAS, 600 × . (3) Electron microscopy showing (a) deposits in subepithelial locations and one in subendothelial location with extensive podocyte effacement in the glomerular capillary loop, (b) deposits in mesangial locations, (c) focal mesangial interposition, and (d, e) subepithelial deposits in different stages, with extensive podocyte effacement

References

    1. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241-250. 10.1097/01.asn.0000108969.21691.5d. Erratum in: J Am Soc Nephrol 2004;15:835-856 - PubMed
    1. Austin HA, 3rd, Illei GG, Braun MJ, Balow JE. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol. 2009;20:901–911. doi: 10.1681/ASN.2008060665. - DOI - PMC - PubMed

Publication types

LinkOut - more resources